Revolution Medicines Inc (NASDAQ: RVMD) is 104.25% higher on its value in year-to-date trading and has touched a low of $20.98 and a high of $62.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RVMD stock was last observed hovering at around $58.63 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $58.58, the stock is 2.17% and 13.99% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.42 million and changing -0.09% at the moment leaves the stock 41.01% off its SMA200. RVMD registered 165.43% gain for a year compared to 6-month gain of 53.47%. The firm has a 50-day simple moving average (SMA 50) of $51.1014 and a 200-day simple moving average (SMA200) of $41.39425.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 16.18% loss in the last 1 month and extending the period to 3 months gives it a 40.14%, and is 2.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.28% over the week and 3.87% over the month.
Revolution Medicines Inc (RVMD) has around 378 employees, a market worth around $9.85B and $0.74M in sales. Profit margin for the company is -76423.32%. Distance from 52-week low is 179.22% and -6.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.48%).
The EPS is expected to grow by 9.62% this year
362.0 institutions hold shares in Revolution Medicines Inc (RVMD), with institutional investors hold 106.33% of the company’s shares. The shares outstanding are 164.67M, and float is at 141.01M with Short Float at 11.60%. Institutions hold 104.06% of the Float.
The top institutional shareholder in the company is with over 27400.0 shares valued at $1.06 million. The investor’s holdings represent 0.0166 of the RVMD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 14.38 million shares valued at $558.02 million to account for 0.0087 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 13.66 million shares representing 0.0083 and valued at over $530.15 million, while BLACKROCK INC. holds 0.0081 of the shares totaling 13.41 million with a market value of $520.39 million.
Revolution Medicines Inc (RVMD) Insider Activity
The most recent transaction is an insider sale by Cislini Jeff, the company’s General Counsel. SEC filings show that Cislini Jeff sold 2,554 shares of the company’s common stock on Nov 15 ’24 at a price of $55.13 per share for a total of $0.14 million. Following the sale, the insider now owns 43080.0 shares.
Still, SEC filings show that on Nov 13 ’24, Kelsey Stephen Michael disposed off 16,666 shares at an average price of $58.65 for $0.98 million. The insider now directly holds 264,408 shares of Revolution Medicines Inc (RVMD).
